The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice
Article in Molecular Metabolism (August 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
To the Brain and Beyond: Neurological Implications of Glucagon-Like Peptide-1 Receptor Agonists.
Article in Journal of Neurosurgical Anesthesiology (July 2024)
Insulin resistance as the molecular link between diabetes and Alzheimer's disease
Article in World Journal of Diabetes (July 2024)